High Potency Active Pharmaceutical Ingredient (HPAPI) Market Size Worth US$ ~51.03 billion by 2031| Growth Plus Reports

Pune, Nov. 19, 2021 (GLOBE NEWSWIRE) -- The Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market is expected to clock US$ ~51.03 billion by 2031 owing to the rising incidence of chronic diseases such as COPD, asthma, cancer, and the rising investments for development of innovative drugs.

Growth Engines

Increasing focus by pharmaceutical companies on development of potent compounds has rose opportunities for HPAPI manufacturers. Pharmaceutical companies are increasingly investing in RandD activities for developing potent drugs as well as expanding their HPAPI manufacturing sites. For instance, in September 2020, Sequens, a pharmaceutical ingredient manufacturer opened a high potency active pharmaceutical production unit at Villeneuve-La-Garenne, France. An investment of US$ 35 million was made for this facility. Such initiatives are anticipated to fuel the growth of HPAPI market during the projected period.

The global high potency active pharmaceutical ingredients market has been analyzed from five perspectives: Product, Drug Type, Manufacturer Type, Application, and Region.

Request a report sample at: https://growthplusreports.com/request-sample-report/?high-potency-active-pharmaceutical-ingredient-hpapi-market

Excerpts from ‘By Product Segmentation’

Based on product, the high potency active pharmaceutical ingredients market has been segmented into synthetic HPAPI and biotech HPAPI. Biotech HPAPI segment is anticipated to be the fastest growing segment in the HPAPI market. Factors such as advancements in HPAPI manufacturing technologies, growing demand for biologics, and increasing investment for RandD of new drugs are contributing to the growth of this segment.

Excerpts from ‘By Region Segmentation’

Regionally, the global high potency active pharmaceutical ingredients market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the market for high potency active pharmaceutical ingredients holding the largest share of the market in 2020. The rising prevalance of various diseases such as cancer, growing investments by regional pharmaceutical companies for RandD activities for new drugs, presence of large number of HPAPI manufacturers, and the increasing demand for potent drugs are some of the factors driving the growth of HPAPI market in North America.

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the global high potency active pharmaceutical ingredients market include:

• Pfizer Inc
• Merck and Co., Inc
• Teva Pharmaceutical Industries Ltd
• Sanofi
• Mylan N.V
• AbbVie Inc
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• AstraZeneca

Get a discount now at https://growthplusreports.com/check-discount/?high-potency-active-pharmaceutical-ingredient-hpapi-market

Table of contents

1. INTRODUCTION
   1. Market Ecosystem
   2. Geographic Scope
   3. Timeline Under Consideration
      1. Historical Years – 2018 & 2019
      2. Base Year – 2020
      3. Forecasted Years – 2021 to 2031
   4. Currency Used in the Report
2. RESEARCH METHODOLOGY
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trend (COVID-19 Perspective)
   2. Pipeline Assessment
   3. Key Players & Their Competitive Positioning (2020)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (HPAPI)MARKET - ANALYSIS & FORECAST, BY PRODUCT
   1. Synthetic
   2. Biotech

TOC continue..

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Speak to an analyst to know Covid-19 impact on this industry: https://growthplusreports.com/speak-to-analyst/?high-potency-active-pharmaceutical-ingredient-hpapi-market

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.